Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
Clinical trials sponsored by Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, explained in plain language.
A research and development subsidiary focused on drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug HW071021 enters human testing for advanced cancers Results expected Sep 2026 (estimated)
- New hope for advanced cancer? early trial of HWS116 begins Results expected Aug 2027 (estimated)
-
New hope for advanced cancer? early trial of HWS116 begins
Disease control Recruiting nowThis early-stage study tests a new drug called HWS116 in about 56 adults with advanced solid tumors (like colorectal, gastric, or pancreatic cancer) that have stopped responding to standard treatments. The main goals are to check the drug's safety and see if it can shrink tumors.…
Phase 1 • Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug HW071021 enters human testing for advanced cancers
Disease control Recruiting nowThis early-stage study tests a new drug, HW071021, in 76 adults with advanced solid tumors (like lung, colorectal, or pancreatic cancer) that have spread or come back. The main goals are to check the drug's safety, find the right dose, and see if it helps shrink tumors. Participa…
Phase 1 • Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New IBD drug candidate begins first human safety tests
Knowledge-focused Recruiting nowThis early-stage study is testing an experimental drug called HW201877 in 104 healthy adults to see if it is safe and how the body processes it. The drug is being developed for inflammatory bowel disease (IBD), but this trial does not involve people with IBD. Participants will re…
Phase 1 • Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC